Results 201 to 210 of about 15,981,489 (330)

The ImproveCareNow Registry: Prediction of different remission rates in pediatric ulcerative colitis

open access: yesJPGN Reports, EarlyView.
Abstract Objectives Identifying predictors of clinical remission in pediatric ulcerative colitis (UC) will impact the therapeutic approach. We aimed to predict time to first (TFR), corticosteroid‐free (TCSFR, ≥3 months corticosteroid withdrawal), and sustained remission (TSR, ≥6 months).
Jonathan Van Hecke   +7 more
wiley   +1 more source

Enteral nutritional therapy for induction of remission in Crohn's disease.

open access: yesCochrane Database of Systematic Reviews, 2018
N. Narula   +5 more
semanticscholar   +1 more source

Direct clinician–pathologist multidisciplinary review and diagnostic revision in children with gastrointestinal disorders

open access: yesJPGN Reports, EarlyView.
Abstract Accurate pediatric gastrointestinal (GI) diagnosis often depends on integrating clinical, endoscopic, and histopathologic information. We evaluated the impact of weekly face‐to‐face multidisciplinary team (MDT) meetings on diagnosis in children undergoing endoscopy or liver biopsy at a tertiary center.
Emma Dahl   +4 more
wiley   +1 more source

Insurance IQ: Demystifying health insurance for young people with inflammatory bowel disease

open access: yesJPGN Reports, EarlyView.
ABSTRACT Many adolescents and young adults with inflammatory bowel disease (AYA‐IBD) lack essential health insurance knowledge. We evaluated an electronic health record (EHR)–based educational intervention to improve insurance literacy. From January to August 2025, AYA‐IBD who had completed a health insurance knowledge assessment and had an upcoming ...
Laura Gilligan, Jeannie S. Huang
wiley   +1 more source

Human immunodeficiency virus infection mimicking very early onset inflammatory bowel disease

open access: yesJPGN Reports, EarlyView.
Abstract Very early onset inflammatory bowel disease (VEO‐IBD), defined as diagnosis before 6 years of age, is often associated with immune dysregulation and monogenic etiologies; however, infectious mimics may be overlooked in low‐prevalence regions. We report a 4‐year‐old male with poor weight gain, intermittent diarrhea, elevated fecal calprotectin,
Rasha Abi Radi Abou Jaoudeh   +2 more
wiley   +1 more source

3rd European Evidence-based Consensus on the Diagnosis and Management of Crohn's Disease 2016: Part 2: Surgical Management and Special Situations.

open access: yesJournal of Crohn's & Colitis, 2017
P. Gionchetti   +18 more
semanticscholar   +1 more source

Acneiform eruption associated with Janus kinase inhibitors in pediatric inflammatory bowel disease: Case series and clinical management guidance

open access: yesJPGN Reports, EarlyView.
Abstract Janus kinase inhibitors (JAKi) are increasingly used for refractory inflammatory bowel disease (IBD) in pediatric patients but are associated with significant dermatologic adverse effects. Acneiform eruptions have been reported in up to 30% of adults, with a greater incidence suspected in adolescents.
Tina H. Tran   +5 more
wiley   +1 more source

Home - About - Disclaimer - Privacy